Northrop Grumman is trading 7.9% down at $488.21 following its second-quarter 2026 earnings release, as investors focused on lower operating margins and profit-taking despite a beat-and-raise performance.
- The company exceeded Q2 estimates for both EPS and revenue and raised its full-year 2026 sales and earnings guidance.
- Management highlighted a record $105 billion backlog and strong program momentum for the B-21 and Sentinel.